Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.
about
Reduced crowding and poor contour detection in schizophrenia are consistent with weak surround inhibitionComputational neuropsychiatry - schizophrenia as a cognitive brain network disorderThe dopamine hypothesis of schizophrenia: version III--the final common pathwayToxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour?Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmissionAntipsychotic drug treatment for elderly people with late-onset schizophreniaSerine racemase binds to PICK1: potential relevance to schizophreniaA peripheral marker for schizophrenia: Increased levels of D3 dopamine receptor mRNA in blood lymphocytesLong-lasting target binding and rebinding as mechanisms to prolong in vivo drug actionNeuregulin 1 and susceptibility to schizophrenia.Occupancy of dopamine D₂ and D₃ and serotonin 5-HT₁A receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain measured using positron emission tomographyNeurotensin-deficient mice show altered responses to antipsychotic drugsLoss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient miceEffects of toxoplasma on human behaviorAnimal models of schizophrenia: a critical reviewIncreased baseline occupancy of D2 receptors by dopamine in schizophreniaMolecular pathology of schizophrenia: more than one disease process?Phospholipase C-β1 Hypofunction in the Pathogenesis of Schizophrenia.A Role for Estrogen in Schizophrenia: Clinical and Preclinical FindingsSpine pruning drives antipsychotic-sensitive locomotion via circuit control of striatal dopamine.A network of dopaminergic gene variations implicated as risk factors for schizophreniaBinding of [3H]haloperidol to dopamine D2 receptors in the rat striatumEffect of neuroleptics and other drugs on monoamine uptake by membranes of adrenal chromaffin granulesAffinity of neuroleptics for D1 receptor of human brain striatumIn Vitro and In Vivo Characterization of the Alkaloid NuciferineFish connectivity mapping: linking chemical stressors by their mechanisms of action-driven transcriptomic profilesCloning of the cDNA and gene for a human D2 dopamine receptorRemoving obstacles in neuroscience drug discovery: the future path for animal models.Schizophrenia.Effects of β-Arrestin-Biased Dopamine D2 Receptor Ligands on Schizophrenia-Like Behavior in Hypoglutamatergic MiceMolecular substrates of schizophrenia: homeostatic signaling to connectivityDeletion of PLCB1 gene in schizophrenia-affected patients.Drosophila Dopamine2-like receptors function as autoreceptorsSelective overexpression of dopamine D3 receptors in the striatum disrupts motivation but not cognition.Disruption of dopamine neuron activity pattern regulation through selective expression of a human KCNN3 mutation.Elucidating the role of neurotensin in the pathophysiology and management of major mental disorders.Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.Is lead exposure in early life an environmental risk factor for Schizophrenia? Neurobiological connections and testable hypotheses.Diverse roles of neurotensin agonists in the central nervous systemHow antipsychotics work-from receptors to reality.
P2860
Q21559665-95518072-CCFD-40F4-8707-E406F2705BA7Q22241226-831AC6CC-B82A-4806-A05B-5F11073C9CE7Q22242827-CFC04F7F-A17B-415D-97BB-9F7594E24E3CQ22306157-D7DDD0B6-C378-4BFA-9CF6-CA7AE16DB813Q23913269-28CD44BA-1DCC-49F9-85F0-309CCB76F9B7Q24203649-F68129C1-FE1B-4563-8EDA-EE22896D0FDFQ24297355-71AA77E5-23AA-45DA-A94A-C513D2EEF84BQ24544101-B77CF6F8-E777-456D-9BD5-CC95E8259251Q24595639-2D98DEA2-BCDE-4C72-AE73-74A3619B5655Q24616921-89E4E3D1-EA84-40CF-B7B8-00658CC49FCAQ24630426-841DAFCF-426C-4D33-B35B-C281A921C59BQ24632801-39A9BDE5-96D4-4FCE-BF21-59E62B913939Q24645188-4074E8BE-5F9E-4293-9272-37C48246E5F9Q24656781-12DEDE1B-A2CB-4799-8BCD-A913CA4FCC9BQ24674909-DDDFBB3A-9FBD-438C-BFF9-E32DC02C2C9AQ24676113-36C270C7-D3A4-4A82-8DB8-5C44E65FD54CQ24676503-069182A0-0176-4EC5-9F09-C7A2844DF381Q26774767-E0EF8E4A-1D8E-45D3-AE01-A32C4899636CQ26778420-253EE079-3ED4-4B03-99AE-67E767B9058AQ27312463-9124614C-B425-4340-8345-AF063020C8CAQ28259093-C3F6D2A8-3E1C-407C-A447-6A7594C20AA0Q28327835-35C64FEB-09E4-4D5A-9BDE-2BEC94FB57B3Q28330782-EE7103C1-E9DC-4D52-BA08-E2C4BE096A54Q28368990-147DAB46-BD50-44D5-BDD7-2C80336FF45DQ28550683-836DB0C3-67D7-4996-AE31-363D017DDBC1Q28601850-493D01B4-0EE5-4150-B00E-1BC5B76226EBQ28645687-598DF61C-E2F8-476A-8646-544788F44914Q28755229-DB847D2E-8BCD-4C58-B538-909B5B9DDAD8Q30251961-3A0E02D2-B32E-4EB5-BC83-2F9B8287D142Q30364693-7F11B83C-346D-49E5-BADF-5638C30F940CQ30383611-1AD5E150-2597-4AE9-B0AD-977F1803A2D2Q30415884-CCC2A669-382A-4F92-B70C-FA31B7D0F8ABQ30423268-DBEB08D8-A251-4434-9808-FE33C6058988Q30423688-DAA80FC3-E6A4-4CBD-9506-54C55A3F57F0Q30425716-D54E5542-1340-44AF-81C2-6D31D4A555F8Q30426586-600BB15F-B72B-4586-8CED-30D573107BB7Q30428213-CDACDE2F-F4D2-4C87-BEE6-9539A965D149Q30454141-0B91B097-37E2-4364-9883-762E0DAE4181Q30456105-A3E1998B-6EBA-4FE6-93A0-92BDC18A14E8Q30457477-D33D3F3B-3502-4A66-BC19-E331B09F1F06
P2860
Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.
description
1976 nî lūn-bûn
@nan
1976 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1976 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
name
Dopamine receptor binding pred ...... es of antischizophrenic drugs.
@ast
Dopamine receptor binding pred ...... es of antischizophrenic drugs.
@en
Dopamine receptor binding pred ...... es of antischizophrenic drugs.
@nl
type
label
Dopamine receptor binding pred ...... es of antischizophrenic drugs.
@ast
Dopamine receptor binding pred ...... es of antischizophrenic drugs.
@en
Dopamine receptor binding pred ...... es of antischizophrenic drugs.
@nl
prefLabel
Dopamine receptor binding pred ...... es of antischizophrenic drugs.
@ast
Dopamine receptor binding pred ...... es of antischizophrenic drugs.
@en
Dopamine receptor binding pred ...... es of antischizophrenic drugs.
@nl
P2093
P2860
P356
P1433
P1476
Dopamine receptor binding pred ...... es of antischizophrenic drugs.
@en
P2093
P2860
P304
P356
10.1126/SCIENCE.3854
P407
P577
1976-04-01T00:00:00Z